|
|
Toxicities |
|||||
| Hematological |
Renal |
Digestive |
Neurological |
Mucosa |
Skin |
|
| TAX-Platine (n = 21) |
8 (38%) |
0 |
7 (33%) |
2 (9%) |
0 |
0 |
| NAV-Platine (n = 11) |
4 (36%) |
2 (18%) |
4 (36%) |
1 (9%) |
0 |
0 |
| 5FU-Platine (n = 23) |
9 (39%) |
3 (13%) |
3 (13%) |
0 |
8 (34%) |
0 |
| Erlotinib (n = 2) |
0 |
0 |
0 |
0 |
0 |
2 (100%) |
| TAX-Beva (n = 1) |
1 (100%) |
0 |
0 |
0 |
0 |
0 |